Structured page family:App landing
Tirzepatide Tracker
A private tirzepatide workflow for people who want clearer weekly dose history, refill timing, symptom notes, and progress tracking without depending on a generic reminder app.
Launch State
The tracker is staged. Join the waitlist to get rollout updates and early access when the first web-based version is ready.
Planned Features
- • Dose log for weekly tirzepatide routines
- • Refill timing and supply countdown
- • Injection-site rotation notes
- • GI side-effect journal
- • Exportable treatment summary for follow-up visits
Privacy and Scope
The tracker roadmap is local-first and privacy-first by default. PeptideScholar does not position the tracker as a diagnostic, prescribing, or insurance tool.
Compare cost and provider paths →Trust Summary
Reviewed 2026-04-11 by PeptideScholar editorial review. This page currently cites 3 official sources.
This landing page describes a planned tracking workflow, not medical advice. Treatment decisions, dose escalation, and missed-dose handling should still follow official instructions and clinician guidance.
Or skip the waitlist
The local-first tracker beta is already live for dose logs, symptoms, and reminders.
Join the Tirzepatide Tracker waitlist
The tracker is staged. Join the waitlist to get rollout updates and early access when the first web-based version is ready.
No spam. Unsubscribe anytime.
Tirzepatide Tracker FAQ
Sources
- 1. Dosing, How to Use and How to Inject ZepboundZepbound • 2026Claim type: clinicalView source →
- 2. Savings Options | Zepbound (tirzepatide)Zepbound • 2026Claim type: pricingView source →
- 3. FDA Approves First Medication for Obstructive Sleep ApneaFDA • 2024-12-20Claim type: regulatoryView source →
This content is for informational purposes only and does not constitute medical advice.